Missing/wrong data?
Log in to edit
Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial
scientific article published on 04 April 2017
Author/s
author: Gian Paolo Fadini, Nicola Vitturi, Mattia Albiero, Elisabetta Iori, Angelo Avogaro, Benedetta Maria Bonora, Giancarlo Zatti, Maria Cristina Marescotti
Work details
Publication date
April 4, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.